Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

4.96

Margin Of Safety %

-25

Put/Call OI Ratio

0.19

EPS Next Q Diff

-0.1

EPS Last/This Y

0.42

EPS This/Next Y

1.01

Price

263.5

Target Price

261.81

Analyst Recom

1.63

Performance Q

28.36

Relative Volume

1.16

Beta

0.53

Ticker: PEN




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2024-12-19PEN243.570.650.017786
2024-12-20PEN242.810.570.038427
2024-12-23PEN240.560.121.093198
2024-12-24PEN240.360.140.733255
2024-12-26PEN240.550.142.003273
2024-12-27PEN239.740.143.003284
2024-12-30PEN238.270.150.493302
2024-12-31PEN237.290.150.083401
2025-01-02PEN240.350.150.363483
2025-01-03PEN241.980.160.433486
2025-01-06PEN237.140.160.303493
2025-01-07PEN251.990.220.053700
2025-01-08PEN257.770.170.406665
2025-01-09PEN257.810.170.376665
2025-01-10PEN250.690.194.937015
2025-01-13PEN2470.216.007151
2025-01-14PEN252.880.223.187255
2025-01-15PEN261.990.190.067062
2025-01-16PEN262.470.190.317059
2025-01-17PEN263.110.190.027103
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2024-12-19PEN243.5817.8- 2.79
2024-12-20PEN242.8317.8- 2.79
2024-12-23PEN240.5517.8- 2.79
2024-12-24PEN240.3617.8- 2.79
2024-12-26PEN240.5417.8- 2.79
2024-12-27PEN239.7017.8- 2.79
2024-12-30PEN238.2417.8- 2.79
2024-12-31PEN237.2317.8- 2.79
2025-01-02PEN239.9717.8- 2.79
2025-01-03PEN242.1217.8- 2.79
2025-01-06PEN237.2117.8- 2.79
2025-01-07PEN252.0117.8- 2.79
2025-01-08PEN257.8117.8- 2.79
2025-01-09PEN257.8117.8- 2.79
2025-01-10PEN250.6817.8- 2.79
2025-01-13PEN246.7617.8- 2.79
2025-01-14PEN253.1717.8- 2.79
2025-01-15PEN261.7717.8- 2.79
2025-01-16PEN262.5217.8- 2.79
2025-01-17PEN263.5017.6- 2.79
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2024-12-19PEN-6.77-0.605.00
2024-12-20PEN-6.77-0.605.00
2024-12-23PEN-6.80-0.605.00
2024-12-24PEN-7.77-0.605.00
2024-12-26PEN-7.74-0.604.82
2024-12-27PEN-7.74-0.604.82
2024-12-30PEN-7.76-0.624.81
2024-12-31PEN-7.84-0.624.81
2025-01-02PEN-7.84-0.624.81
2025-01-03PEN-7.82-0.624.81
2025-01-06PEN-7.71-0.614.81
2025-01-07PEN-7.73-0.614.81
2025-01-08PEN-7.79-0.614.81
2025-01-09PEN-7.79-0.614.81
2025-01-10PEN-7.79-0.614.81
2025-01-13PEN-7.79-0.594.96
2025-01-14PEN-7.79-0.594.96
2025-01-15PEN-7.79-0.594.96
2025-01-16PEN-7.79-0.594.96
2025-01-17PEN-7.79-0.594.96
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

0.85

Avg. EPS Est. Current Quarter

0.9

Avg. EPS Est. Next Quarter

0.75

Insider Transactions

-7.79

Institutional Transactions

-0.59

Beta

0.53

Average Sales Estimate Current Quarter

311

Average Sales Estimate Next Quarter

317

Fair Value

197.27

Quality Score

77

Growth Score

94

Sentiment Score

66

Actual DrawDown %

24.4

Max Drawdown 5-Year %

-62.6

Target Price

261.81

P/E

306.22

Forward P/E

69.31

PEG

11.06

P/S

8.7

P/B

9.16

P/Free Cash Flow

75.42

EPS

0.86

Average EPS Est. Cur. Y​

2.79

EPS Next Y. (Est.)

3.79

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

2.97

Relative Volume

1.16

Return on Equity vs Sector %

-15.9

Return on Equity vs Industry %

-9.5

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

Penumbra, Inc.
Sector: Healthcare
Industry: Medical Devices
Employees: 4200
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
stock quote shares PEN – Penumbra, Inc. Stock Price stock today
news today PEN – Penumbra, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch PEN – Penumbra, Inc. yahoo finance google finance
stock history PEN – Penumbra, Inc. invest stock market
stock prices PEN premarket after hours
ticker PEN fair value insiders trading